Clinical Trials Browser

Brain Neoplasms, Carcinoma, Renal Cell, Chondrosarcoma, Kidney Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT02821182 2022-12-29

A Phase II Trial of Stereotactic Body Radiotherapy With Concurrent Anti-PD1 Treatment in Metastatic Melanoma.

Phase 2 Completed

20 enrolled

Dermatologic

Melanoma

NCT05077280 2022-12-06

A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma

Phase 2 Unknown

40 enrolled

Dermatologic

Uveal Melanoma, Neoplasm Metastasis

NCT02097732 2021-05-12

Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery

Phase 2 Terminated

4 enrolled 10 charts

CNSDermatologic

Brain Neoplasms, Melanoma

NCT04042506 2021-04-12

SBRT as a Vaccination for Metastatic Melanoma

Phase 2 Withdrawn

Dermatologic

Melanoma

NCT01970527 2020-02-13

Phase II Trial of Stereotactic Body Radiotherapy Followed by Ipilimumab in Treating Patients With Stage IV Melanoma

Phase 2 Terminated

23 enrolled 13 charts

Dermatologic

Melanoma

NCT01721603 2018-01-23

Dabrafenib and Trametinib With Radiosurgery in Melanoma Brain Mets

Phase 2 Terminated

2 enrolled 7 charts

Dermatologic

Melanoma

NCT01973608 2016-10-31

MSB0010445 and Stereotactic Body Radiation Therapy in Advanced Melanoma

Phase 2 Terminated

12 enrolled 10 charts

Dermatologic

Melanoma

NCT00587964 2016-02-22

Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases

Phase 2 Completed

51 enrolled 6 charts

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Sarcoma, Testicular Neoplasms

NCT02662725 2016-01-25

IPI+RTS

Phase 2 Completed

73 enrolled

CNSDermatologic

Brain Neoplasms, Melanoma

NCT00003911 2013-01-31

S9903: Whole Brain Radiotherapy Followed By Stereotactic Radiosurgery for Limited Malignant Melanoma Brain Metastases

Phase 2 Terminated

2 enrolled

CNSDermatologic

Brain Neoplasms, Melanoma, Neoplasm Metastasis

Clinical Trials

Testing the Addition of Radiation Therapy to Immunotherapy for Merkel Cell Carcinoma

SBRT/IL-2

Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord

BEPCOME-MB

Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases

Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma

Stereotactic Radiosurgery in Treating Patients With Greater Than 3 Melanoma Brain Metastases

ABC-X

Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

Stereotactic Body Radiation Therapy and Aflibercept in Treating Patients With Uveal Melanoma

EBRAIN-MEL

Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases

Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma

CHEERS

Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma

A Phase II Trial of Stereotactic Body Radiotherapy With Concurrent Anti-PD1 Treatment in Metastatic Melanoma.

A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma

Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery

SBRT as a Vaccination for Metastatic Melanoma

Phase II Trial of Stereotactic Body Radiotherapy Followed by Ipilimumab in Treating Patients With Stage IV Melanoma

Dabrafenib and Trametinib With Radiosurgery in Melanoma Brain Mets

MSB0010445 and Stereotactic Body Radiation Therapy in Advanced Melanoma

Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases

IPI+RTS

S9903: Whole Brain Radiotherapy Followed By Stereotactic Radiosurgery for Limited Malignant Melanoma Brain Metastases